A compound having the formula (I):
for use in treating disease; a composition comprising said fused quinonic compound of formula (I) and at least one pharmaceutically acceptable carrier; as well as a method of modulating a Janus Kinase-Signal Transduction and Activators of Transcription (JAK-STAT) pathway. The activation of a JAK-STAT pathway is associated with several disease states such as immunological and inflammatory diseases, hyperproliferative disorders including cancer, and myeloproliferative diseases.
申请公布号
EP2690094(A1)
申请公布日期
2014.01.29
申请号
EP20120177591
申请日期
2012.07.24
申请人
CENTRO ATLANTICO DEL MEDICAMENTO S.A (CEAMED, S.A)